Selexipag Designated as Orphan Drug for CTEPH: MHLW

June 21, 2016
The Ministry of Health, Labor and Welfare (MHLW) said on June 20 that it has granted orphan drug designation for Nippon Shinyaku’s selexipag for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH). More specifically, the designation was given for the...read more